Teva Neuroscience Canada

Our goal? To support patients, their families, health professionals, caregivers and the organizations involved in the day-to-day struggle against multiple sclerosis and to help patients receive optimal care. Our overall approach focuses first and foremost on individuals diagnosed with Multiple Sclerosis.

Through medical research, educational programs, innovative support services and health management programs, Teva Neuroscience in Canada pursues a mission to enhance the management of multiple sclerosis improving the lives and quality of care for people diagnosed with MS.

Since founding Teva Neuroscience in Canada, we have been committed to implementing innovative concepts with a view to optimizing the treatment of multiple sclerosis. To be able to provide day-to-day management of the disease, it is essential to join forces with all those concerned: patients, their families and health care providers. This firm commitment takes three forms:

• The marketing and commercial development of a therapy for multiple sclerosis.
• Implementation of Shared Solutions^®, a personalized support system and information center.
• Active involvement and sponsorship of clinical research and continuing medical education across Canada.

"Teva Neuroscience in Canada, in conjunction with Teva Neuroscience in the United States and our parent organizations are global leaders in sponsoring research in multiple sclerosis. Over the next few years, we want to build on the strength of our expertise, continue to enhance the partnership established with key stakeholders in the field of MS and build upon the competencies established in order to make Teva Neuroscience a leader in the treatment of multiple sclerosis across North America."

Jean Godin
General Manager of Teva Neuroscience, Montreal, Quebec, Canada